SO Sowemimo-Coker, ML Scott, M Long… - US Patent …, 2011 - Google Patents IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIM US007923203B2 (12) United States Patent ao) Patent no.: us 7,923,203 B2 Sowemimo-Coker et al. (45) Date of Patent: Apr. 12,2011 (54) METHOD OF USE OF A PLATELET/NUCLEATED CELL CONCENTRATE FROM BONE MARROW OR BLOOD TO ... Related articles - All 3 versions
[PDF] from haematologica.it…, R Lai, N Kumar, SD Smith, ED Hsi - Haematologica, 2011 - haematologica.org Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E- ... Cited by 1 - Related articles - All 8 versions
CJ Stotler… - Adult Acute Lymphocytic Leukemia, 2011 - Springer ... Historical data reveal 5-year survival rates with conventional chemotherapy of 10–20% [3, 4]. These poor results stimu- lated interest in high-dose chemotherapy followed by bone marrow transplantation (BMT). ... Christy J. Stotler and Edward Copelan ... Related articles - All 2 versions
…, B McClune, B Oran, ED Warlick… - Bone Marrow …, 2011 - nature.com Umbilical cord blood (UCB) has increased access to hematopoietic cell transplantation (HCT) for patients without HLA-matched sibling donors (MSD). We compared outcomes of HCT using MSD (N=38) or UCB (N=60) among older patients (age 55 years) with AML or ... All 3 versions